Telehealth providers in Kansas
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in Kansas. What Kansas requires of telehealth prescribers and pharmacies, plus listings with their verification status.
Kansas at a glance
- Pharmacy regulator
- Kansas State Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving Kansas
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Kansas (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in Kansas
The Kansas Telemedicine Act (2018) defines telemedicine as the delivery of healthcare services while the patient and provider are at different sites, and says it shall be provided by means of real-time two-way interactive audio, visual, or audio-visual communications, including the application of secure video conferencing or store-and-forward technology to provide or support healthcare delivery (K.S.A. 40-2,211(a)(5)). A physician-patient exchange that consists solely of e-mail or fax is not telemedicine. K.S.A. 40-2,212 states that telemedicine may be used to establish a valid provider-patient relationship, that in-person standards of practice and conduct apply, that the provider must give guidance on follow-up care, and that with patient consent the provider must send a report to the patient's primary care or treating physician within three business days. K.S.A. 40-2,214 directed the State Board of Healing Arts to adopt rules on prescribing by telemedicine, and K.A.R. 100-77-3 says the same laws and regulations that apply to in-person prescribing, including for controlled substances, apply to prescribing by telemedicine. The Pharmacy Act adds that a prescription issued solely on the basis of an internet-based questionnaire or consultation without an appropriate prescriber-patient relationship is not a valid prescription order (K.S.A. 65-1626(yyy)). This record leaves asynchronous prescribing unknown because the law is ambiguous: the definition requires real-time two-way communication yet also names store-and-forward technology, and no statute or Board regulation says whether a purely asynchronous first encounter counts as telemedicine. [2] [3] [7] [8] [9] [10]
Compounded GLP-1 access in Kansas
Kansas patients using telehealth GLP-1 programs should confirm the prescriber holds a Kansas license and that the dispensing pharmacy has a Kansas nonresident pharmacy registration under K.S.A. 65-1657. The Kansas Board of Pharmacy's statement on compounding and dispensing GLP-1 and GIP receptor agonists (last updated August 26, 2026) says semaglutide and tirzepatide are no longer in shortage, that no salt form of either may be used in a compounded drug, and that even when compounding is otherwise allowed, a non-pharmaceutical grade bulk substance or one not made in an FDA-registered establishment is prohibited. It also says pre-printed or check-box prescriptions may not document the patient-specific need that copies of approved drugs require, and that retatrutide and cagrilintide cannot be used to compound under federal law. [6] [11] [13] [14]
Research use only sellers in Kansas
K.S.A. 65-1657 bars unregistered nonresident pharmacies from shipping prescription drugs into Kansas and from advertising to Kansas residents. The Kansas Board of Pharmacy's GLP-1 statement adds that compounding pharmacies must use pharmaceutical-grade active ingredients, not research use, investigational, food, or supplement grade, with a certificate of analysis naming the original manufacturer, and that a pharmacist may not dispense a product compounded in a non-compliant manner. [6] [11] [15]
How to check a telehealth provider in Kansas
- Confirm the prescriber is licensed or registered to treat patients located in Kansas; the telehealth rules above explain what Kansas requires. [2] [3] [7] [8] [9] [10]
- Ask which pharmacy will fill the prescription and check it in the Kansas State Board of Pharmacy license lookup. [1] [4] [5] [6] [11] [12]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Kansas. [6] [11] [15]
Common questions in Kansas
Can a telehealth provider start me on a GLP-1 in Kansas without an office visit?
Yes, if the provider is licensed in Kansas and meets in-person standards of practice. K.S.A. 40-2,212 says telemedicine may be used to establish a valid provider-patient relationship, and prescribing by telemedicine follows the same laws as in-person prescribing. Kansas law does not settle whether a visit with no live contact is enough: the telemedicine definition requires real-time two-way communication yet also names store-and-forward technology. A prescription based only on an internet questionnaire, without an appropriate prescriber-patient relationship, is not valid under K.S.A. 65-1626(yyy). [7] [8] [9] [10]
Will my regular doctor be told about a telehealth prescription in Kansas?
If you consent and have a primary care or treating physician, K.S.A. 40-2,212 requires the telemedicine provider to send that physician a report of the treatment within three business days. [8]
What does an out-of-state pharmacy need to ship compounded peptides to Kansas?
A Kansas nonresident pharmacy registration under K.S.A. 65-1657, renewed annually. The law covers shipments to patients, their agents, and prescribers' offices, and unregistered pharmacies may not advertise to Kansas residents. [11]
Sources
- [1]Kansas State Board of Pharmacy
- [2]Kansas State Board of Healing Arts
- [3]K.A.R. 100-77-3, Prescribing drugs by means of telemedicine (Kansas Secretary of State)
- [4]K.A.R. Article 68-13, State Board of Pharmacy regulations (68-13-2 definitions, 68-13-3 nonsterile, 68-13-4 sterile preparations)
- [5]Kansas Board of Pharmacy: Compounding compliance (House Bill 2068 adoption of USP 795, 797, and 825)
- [6]Kansas Board of Pharmacy: Statement on compounding and dispensing of compounded GLP-1 and GIP receptor agonists (updated August 26, 2026)
- [7]K.S.A. 40-2,211, Kansas Telemedicine Act definitions
- [8]K.S.A. 40-2,212, Telemedicine confidentiality, provider-patient relationship, and standards of practice
- [9]K.S.A. 40-2,214, Prescribing of drugs via telemedicine (rulemaking)
- [10]K.S.A. 65-1626, Pharmacy Act definitions (valid prescription order)